Average Co-Inventor Count = 4.92
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (16 from 2,405 patents)
2. Zymeworks Inc. (1 from 56 patents)
3. Merck Sharp + Dohme B.v. (1 from 55 patents)
16 patents:
1. 12441792 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
2. 12435133 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
3. 12122834 - Anti-PD-1 antibodies
4. 12102681 - Anti-LAG3 antibodies and antigen-binding fragments
5. 12102680 - Anti-TIGIT antibodies
6. 11958902 - Anti-TIGIT antibodies
7. 11278620 - Anti-LAG3 antibodies and antigen-binding fragments
8. 11207406 - Anti-LAG3 antibodies and antigen-binding fragments
9. 11111297 - Antibodies specific for immunoglobulin-like transcript 3 (ILT3) and uses thereof
10. 11072658 - Anti-PD-1/LAG3 bispecific antibodies
11. 11045547 - Anti-LAG3 antibodies and antigen-binding fragments
12. 10898571 - Anti-LAG3 antibodies and antigen-binding fragments
13. 10766957 - Anti-TIGIT antibodies
14. 10618958 - Anti-TIGIT antibodies
15. 10556957 - Anti-CD27 antibodies